Meeting of the Advisory Committee on Organ Transplantation, 14950-14951 [2019-07278]
Download as PDF
<![CDATA[
14950
Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices
Comments on this ICR should be
received no later than June 11, 2019.
DATES:
Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N136B, 5600 Fishers
Lane, Rockville, MD 20857.
ADDRESSES:
To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Lisa Wright-Solomon, the HRSA
Information Collection Clearance Officer
at (301) 443–1984.
FOR FURTHER INFORMATION CONTACT:
When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Rural Communities Opioid Response
Program Performance Measures, OMB
No. 0906–xxxx, New.
Abstract: The Rural Communities
Opioid Response Program (RCORP) is a
multi-initiative program that aims to: (1)
Support treatment for and prevention of
substance use disorder (SUD), including
opioid use disorder (OUD); and (2)
reduce morbidity and mortality
associated with SUD, to include OUD,
by improving access to and delivering
prevention, treatment, and recovery
support services to high-risk rural
communities. To support this purpose,
RCORP grant initiatives include:
SUPPLEMENTARY INFORMATION:
• RCORP-Planning grants to
strengthen the capacity of multi-sector
consortia to collaborate and develop
plans to deliver SUD/OUD prevention,
treatment, and recovery services in
high-risk rural communities;
• RCORP-Implementation grants to
fund established networks and consortia
to deliver SUD/OUD prevention,
treatment, and recovery activities in
high-risk rural communities; and
• RCORP-Medication Assisted
Treatment Expansion grants to enhance
access to medication-assisted treatment
within eligible hospitals, health clinics,
or tribal organizations in high-risk rural
communities.
Additionally, all RCORP grant award
recipients will be supported by five
cooperative agreements: RCORPTechnical Assistance, which provides
extensive technical assistance to award
recipients; RCORP-Evaluation, which
will evaluate the impact of the RCORP
initiative on rural communities; and
three RCORP-Centers of Excellence,
which will disseminate best practices
related to the treatment for and
prevention of substance use disorders
within rural communities.
Need and Proposed Use of the
Information: For this program,
performance measures were developed
to provide data on each RCORP
initiative and to enable HRSA to
provide aggregate program data required
by Congress under the Government
Performance and Results Act of 1993.
These measures cover the principal
topic areas of interest to the Federal
Office of Rural Health Policy (FORHP),
including: (a) Provision of, and referral
to, substance use disorder treatment and
support services; (b) substance use
disorder prevention, treatment, and
recovery process and outcomes; (c)
education of health care providers and
community members; (d) number of
fatal and non-fatal opioid-related
overdoses; and (e) consortium strength
and sustainability. All measures will
speak to FORHP’s progress toward
meeting the goals set.
Likely Respondents: The respondents
will be the grant award recipients of the
Rural Communities Opioid Response
Program initiatives.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Rural Communities Opioid Response Program Performance Measures .................................................................
243
2
486
5.66
2,750
Total ..............................................................................
243
........................
486
........................
2,750
HRSA specifically requests comments
on: (1) The necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
jbell on DSK30RV082PROD with NOTICES
Number of
responses per
respondent
(annually)
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Amy P. McNulty,
Acting Director, Division of the Executive
Secretariat.
Health Resources and Services
Administration
[FR Doc. 2019–07221 Filed 4–11–19; 8:45 am]
Meeting of the Advisory Committee on
Organ Transplantation
BILLING CODE 4165–15–P
Health Resources and Services
Administration (HRSA), HHS.
ACTION: Notice; correction.
AGENCY:
The Advisory Committee on
Organ Transplantation (ACOT) meeting
has been rescheduled due to an
unanticipated conflict and will now be
held on Monday, May 20, 2019, from
SUMMARY:
VerDate Sep<11>2014
18:18 Apr 11, 2019
Jkt 247001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\12APN1.SGM
12APN1
Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices
10:00 a.m.–4:00 p.m. Eastern Time. The
meeting will be held by webinar and
conference call. The webinar link,
conference call-in number, agenda, and
instructions for registration will be
posted 15 business days before the
meeting on the ACOT website at https://
www.organdonor.gov/about-dot/
acot.html.
FOR FURTHER INFORMATION CONTACT:
Robert Walsh, Designated Federal
Officer, at the Healthcare Systems
Bureau, Division of Transplantation,
HRSA, 5600 Fishers Lane, 8W60,
Rockville, Maryland 20857; 301–443–
6839; or RWalsh@hrsa.gov.
New meeting date: Monday, May 20,
2019, rather than April 16, 2019, as
previously announced.
Amy P. McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2019–07278 Filed 4–11–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Statement of Organization, Functions,
and Delegations of Authority
Office of the Assistant
Secretary for Health, Office of Infectious
Disease Policy, HHS.
ACTION: Notice.
AGENCY:
The Office of the Assistant
Secretary for Health, National Vaccine
Program Office organization has
modified its organizational structure.
DATES: This new organizational
structure was approved by the Secretary
of Health and Human Services and takes
effect on April 6, 2019.
FOR FURTHER INFORMATION CONTACT: Tara
Broido, Acting Director, Office of
Communications, Office of the Assistant
Secretary for Health, 200 Independence
Ave. SW, Room 715–G, Washington, DC
20201, Phone 202.690.7694.
SUPPLEMENTARY INFORMATION: Part A
(Office of the Secretary, U.S.
Department of Health and Human
Services) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (60 FR 27804, dated October
31, 1995, and corrected at 75 FR 53304,
August 31, 2010, and amended most
recently at 82 FR 3005, dated January 5,
2017) is amended to reflect the merger
of the National Vaccine Prevention
Office, Office of the Assistant Secretary
for Health (OASH) with the Office of
HIV/AIDS and Infectious Disease Policy,
OASH and create the Office of
jbell on DSK30RV082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:18 Apr 11, 2019
Jkt 247001
Infectious Disease Policy (OIDP), OASH,
which will be responsible for
administering and implementing the
statutory responsibilities of the National
Vaccine Program, as well as the current
responsibilities of the Office of HIV/
AIDS and Infectious Disease Policy.
This reorganization is being undertaken
to create a more effective structure that
better reflects the two offices’ missions
and streamlines operations.
Under Part C, Section C–P,
Organization and Function, make the
following changes:
• Retitle all references to the National
Vaccine Program Office (ACP) and to
the Office of Infectious Disease Policy
(ACP).
• Add the current reference to the
Office of Infectious Disease Policy
(ACP), The Office of Infectious Disease
Policy, headed by the Deputy Assistant
Secretary for Infectious Disease, will be
responsible for providing advice and
recommendations to the Assistant
Secretary for Health on issues pertaining
to: blood and tissues safety and
availability; HIV/AIDS, viral hepatitis
and other infectious diseases; and
vaccines and immunization. The Office
of Infectious Disease Policy will be
responsible for administering and
implementing the statutory
responsibilities of the National Vaccine
Program.
Under Part C, Section C–J,
Organization and Function, make the
following changes:
• Delete all references to the
organizational structure of the Office of
HIV/AIDS and Infectious Disease Policy
(ACJ).
• Retitle all references to the function
of the Office of HIV/AIDS and Infectious
Disease Policy (ACJ) to the Office of
Infectious Disease Policy (ACP).
II. Delegations of Authority: All
delegations and re-delegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, if allowed, provided they
are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Alex M. Azar II,
Secretary.
[FR Doc. 2019–07126 Filed 4–10–19; 4:15 pm]
BILLING CODE 4150–44–P
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
14951
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Statement of Organization, Functions,
and Delegations of Authority
Office of the Assistant
Secretary for Health, Office of
Population Affairs, HHS.
ACTION: Notice.
AGENCY:
The Office of the Assistant
Secretary for Health, Office of
Population Affairs organization has
modified its organizational structure.
DATES: This new organizational
structure was approved by the Secretary
of Health and Human Services and takes
effect on April 6, 2019.
FOR FURTHER INFORMATION CONTACT: Tara
Broido, Acting Director, Office of
Communications, Office of the Assistant
Secretary for Health, 200 Independence
Ave. SW, Room 715–G, Washington, DC
20201, Phone 202.690.7694.
SUPPLEMENTARY INFORMATION: Part A
(Office of the Secretary, U.S.
Department of Health and Human
Services) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (60 FR 27804, dated October
31, 1995, and corrected at 75 FR 53304,
August 31, 2010, and amended most
recently at 82 FR 3005, dated January 5,
2017) is amended to reflect the
reorganization of the Office of
Population Affairs (OPA), Office of the
Assistant Secretary for Health (OASH).
This reorganization is being undertaken
to create a more effective structure that
better reflects OPA’s priorities and
streamlines operations. This
reorganization realigns Title X family
planning project staff in the 10 HHS
Regional Offices, currently reporting to
the OASH Regional Health
Administrators, to report directly to
OPA Headquarters; and merges the
Office of Adolescent Health along with
the Teen Pregnancy Prevention program
and other adolescent health activities
that it currently administers, into the
Office of Population Affairs.
Under Part C, Section C–G, add the
current reference: The Office of
Population Affairs, headed by the
Deputy Assistant Secretary for
Population Affairs, will include the
Office of Adolescent Health. The Office
of Population Affairs will be responsible
for implementing and administering the
Title X family planning program and
will manage the Office of Adolescent
Health, which will be headed by a
director, will implement and administer
the Teen Pregnancy Prevention program
and other adolescent health activities.
SUMMARY:
E:\FR\FM\12APN1.SGM
12APN1
]]>Agencies
[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Pages 14950-14951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07278]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Organ Transplantation
AGENCY: Health Resources and Services Administration (HRSA), HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Advisory Committee on Organ Transplantation (ACOT) meeting
has been rescheduled due to an unanticipated conflict and will now be
held on Monday, May 20, 2019, from
[[Page 14951]]
10:00 a.m.-4:00 p.m. Eastern Time. The meeting will be held by webinar
and conference call. The webinar link, conference call-in number,
agenda, and instructions for registration will be posted 15 business
days before the meeting on the ACOT website at https://www.organdonor.gov/about-dot/acot.html.
FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal
Officer, at the Healthcare Systems Bureau, Division of Transplantation,
HRSA, 5600 Fishers Lane, 8W60, Rockville, Maryland 20857; 301-443-6839;
or [email protected].
New meeting date: Monday, May 20, 2019, rather than April 16, 2019,
as previously announced.
Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2019-07278 Filed 4-11-19; 8:45 am]
BILLING CODE 4165-15-P
